<?xml version="1.0" encoding="UTF-8"?>
<p>Multidrug resistance (MDR), which is often of a multiple type, is a real obstacle to the pharmacological treatment of many types of cancer diseases and can be defined as the ability of cancer cells to acquire resistance to both conventional and novel chemotherapy agents [
 <xref rid="B1-pharmaceuticals-14-00111" ref-type="bibr">1</xref>]. In this paper we focus on drug resistance acquired after treatment with a chemotherapic drug which is a complex and multifactorial phenomenon.
</p>
